New Targets for Treating the Underlying Pathophysiology and Nonmotor Aspects of Parkinson’s Disease

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|13|7|1273-1279

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.13, Iss.7, 2014-09, pp. : 1273-1279

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug treatment of non-motor symptoms in Parkinson’s disease

By Müller Thomas  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 4, 2002-04 ,pp. : 381-388

Informa Healthcare

Access to resources Recommend Favorite

Psychotic symptoms in Parkinson’s disease: pathophysiology and management

By Bosboom JLW   Wolters ECh  

Expert Opinion on Drug Safety, Vol. 3, Iss. 3, 2004-05 ,pp. : 209-220

Informa Healthcare

Access to resources Recommend Favorite

Mitochondria: Prospective Targets for Neuroprotection in Parkinson’s Disease

By  

Current Pharmaceutical Design, Vol. 20, Iss. 35, 2014-10 ,pp. : 5558-5573

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Novel Perspectives for Parkinson’s Disease Therapy: Insights from the Latest Advances in Disease Pathophysiology, Diagnostic and Experimental Tools and Molecular Targets)

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 8, 2013-12 ,pp. : 1083-1085

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment Benefit and Daily Drug Costs Associated with Treating Parkinson’s Disease in a Parkinson’s Disease Clinic

By Müller T.  

CNS Drugs, Vol. 18, Iss. 2, 2004-01 ,pp. : 105-111

Adis International

Access to resources Recommend Favorite